|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 479 studies with search of: | Ritonavir OR Norvir[TREATMENT] AND HIV [CONDITION] |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Active, not recruiting |
Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study
|
||||
| 2 | Active, not recruiting |
Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
|
||||
| 3 | Completed |
Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People
|
||||
| 4 | Completed |
Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART
|
||||
| 5 | Completed |
Efficacy and Safety of Single Versus Double Ritonavir-Boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens
|
||||
| 6 | Completed |
Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor
|
||||
| 7 | Not yet recruiting |
Randomised and Prospective Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens
|
||||
| 8 | Active, not recruiting |
Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue
|
||||
| 9 | Completed |
Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
|
||||
| 10 | Completed |
Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir
|
||||
| 11 | Completed |
Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects
|
||||
| 12 | Recruiting |
Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
|
||||
| 13 | Recruiting |
Lopinavir/Ritonavir (Kaletra)PK
|
||||
| 14 | Completed |
A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients
|
||||
| 15 | Recruiting |
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With TMC114r (Ritonavir), and TMC125 (Etravirine) in HIV-1 Infected Pregnant Women
|
||||
| 16 | Completed |
ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects
|
||||
| 17 | Not yet recruiting |
Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir®
|
||||
| 18 | Recruiting |
Genetic Predictors of Variability in the Drug-Drug Interaction Between Darunavir/Ritonavir and Pravastatin
|
||||
| 19 | Completed |
Dose Reduction of Lopinavir in Children
|
||||
| 20 | Active, not recruiting |
"The Once A Day Protease Inhibitor Regimens"
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|